AbCellera Biologics Inc.(ABCL)
Biotechnology
Antibody Engineering (mAbs, bispecifics, ADCs)
| Filing Date | Insider | Type | 10b5-1 | Net Shares | Ownership change | Avg. Price | Value | Filing |
|---|---|---|---|---|---|---|---|---|
| 2026-05-18 | Montalbano John S. Director | Purchase | +20,000 | +9.05%241,000 | $4.77 | $95,400 | View SEC filing | |
| 2026-03-02 | Thermopylae Holdings Ltd. 10% Owner | Purchase | +38,000 | +0.07%56,134,097 | $3.44 | $130,720 | View SEC filing | |
| 2026-02-27 | Thermopylae Holdings Ltd. 10% Owner | Purchase | +177,457 | +0.32%56,096,097 | $3.27 | $580,284 | View SEC filing | |
| 2026-02-27 | Booth Andrew Chief Financial Officer | Purchase | +42,600 | +27.84%195,600 | $3.42 | $145,692 | View SEC filing | |
| 2025-11-26 | Montalbano John S. Director | Purchase | +50,000 | +29.24%221,000 | $3.57 | $178,460 | View SEC filing | |
| 2025-03-11 | Thermopylae Holdings Ltd. 10% Owner | Purchase | +343,631 | +0.62%56,143,640 | $2.16 | $742,243 | View SEC filing | |
| 2025-03-10 | Montalbano John S. Director | Purchase | +25,000 | +17.12%171,000 | $2.30 | $57,500 | View SEC filing | |
| 2025-03-07 | Montalbano John S. Director | Purchase | +60,000 | +69.77%146,000 | $2.34 | $140,568 | View SEC filing | |
| 2024-08-29 | Thermopylae Holdings Ltd. 10% Owner | Purchase | +283,516 | +0.51%56,086,009 | $2.61 | $739,977 | View SEC filing | |
| 2023-11-08 | Montalbano John S. Director | Purchase | +30,000 | +53.57%86,000 | $4.58 | $137,400 | View SEC filing | |
| 2023-09-26 | Hayden Michael R Director | Purchase | +20,000 | +1.53%1,323,397 | $4.91 | $98,200 | View SEC filing | |
| 2023-09-14 | Lecault Veronique Chief Operating Officer | Purchase | +20,000 | +0.99%2,040,122 | $5.19 | $103,800 | View SEC filing | |
| 2023-08-09 | Hayden Michael R Director | Purchase | +30,000 | +2.36%1,303,397 | $5.90 | $177,000 | View SEC filing | |
| 2023-05-26 | Booth Andrew Chief Financial Officer | Purchase | +14,500 | +10.47%153,000 | $6.85 | $99,325 | View SEC filing | |
| 2023-05-26 | Thermopylae Holdings Ltd. 10% Owner | Purchase | +153,000 | +0.27%56,012,493 | $6.52 | $997,728 | View SEC filing | |
| 2022-12-20 | Thermopylae Holdings Ltd. 10% Owner | Purchase | +85,102 | +0.15%55,859,493 | $10.10 | $859,249 | View SEC filing | |
| 2022-08-22 | Thermopylae Holdings Ltd. 10% Owner | Purchase | +200,000 | +0.36%55,844,391 | $11.46 | $2,292,460 | View SEC filing | |
| 2022-06-15 | Thermopylae Holdings Ltd. 10% Owner | Purchase | +64,088 | +0.12%55,644,391 | $8.03 | $514,908 | View SEC filing | |
| 2022-06-08 | Thermopylae Holdings Ltd. 10% Owner | Purchase | +64,545 | +0.12%55,580,303 | $7.50 | $483,965 | View SEC filing | |
| 2022-05-17 | Lecault Veronique Chief Operating Officer | Purchase | +200,000 | +12.74%1,770,122 | $6.34 | $1,267,780 | View SEC filing | |
| 2022-05-17 | Thermopylae Holdings Ltd. 10% Owner | Purchase | +300,000 | +0.54%55,515,758 | $7.26 | $2,176,530 | View SEC filing | |
| 2022-05-16 | Thermopylae Holdings Ltd. 10% Owner | Purchase | +1,408,468 | +2.62%55,215,758 | $6.41 | $9,021,801 | View SEC filing | |
| 2022-05-16 | Booth Andrew Chief Financial Officer | Purchase | +85,000 | +158.88%138,500 | $5.79 | $492,150 | View SEC filing | |
| 2022-03-04 | Montalbano John S. Director | Purchase | +10,000 | +21.74%56,000 | $8.54 | $85,400 | View SEC filing | |
| 2022-03-03 | Montalbano John S. Director | Purchase | +20,000 | +76.92%46,000 | $9.05 | $181,000 | View SEC filing |
1-25 of 43